Stock EMBC EMBECTA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Embecta Corp.

Equities

EMBC

US29082K1051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
12.37 USD -0.48% Intraday chart for Embecta Corp. -5.79% -34.65%
May. 16 Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
May. 09 Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup DJ

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Morgan Stanley Adjusts Price Target on to $16 From $15, Maintains Underweight Rating
MT
Morgan Stanley Adjusts Price Target on Embecta to $15 From $16, Maintains Underweight Rating
MT
BofA Trims Price Target on Embecta to $17 From $25, Keeps Underperform Rating
MT
Morgan Stanley Trims Price Target on Embecta to $16 From $19, Maintains Underweight Rating
MT
Morgan Stanley Adjusts Price Target on Embecta to $19 From $29, Maintains Underweight Rating
MT
Morgan Stanley Downgrades Embecta to Underweight From Equalweight, Price Target is $28
MT
Morgan Stanley Adjusts Price Target on Embecta to $31 From $33, Maintains Equal-Weight Rating
MT
Morgan Stanley Adjusts Price Target on Embecta Corp. to $33 From $36, Reiterates Equalweight Rating
MT
BTIG Initiates Embecta at Neutral
MT
Morgan Stanley Adjusts Price Target on Embecta to $36 From $33, Keeps Equalweight Rating
MT
Morgan Stanley Initiates Embecta at Equalweight with $33 Price Target
MT
BofA Securities Initiates Embecta at Underperform with $25 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EMBC Stock
  4. News Embecta Corp.
  5. Analyst Reco.